Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With

See also
Status	Clinical Trial	Phase
Completed	`NCT02502396` - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
Withdrawn	`NCT03508258` - Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)
Terminated	`NCT03715725` - A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.
Active, not recruiting	`NCT05565599` - An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation	N/A
Completed	`NCT02756481` - Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela	N/A
Completed	`NCT04193826` - The Conformal Prague Study	N/A
Completed	`NCT01884350` - Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)	Phase 4
Completed	`NCT02422602` - Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program	N/A
Recruiting	`NCT02147444` - Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation	N/A
Completed	`NCT01857622` - Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment	Phase 3
Recruiting	`NCT04829929` - Evaluation od Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk	N/A
Recruiting	`NCT05761704` - Exploratory Observation of Two Short-term Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With Non-valvular Atrial Fibrillation	N/A
Recruiting	`NCT04559243` - Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events
Completed	`NCT03570047` - Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation
Terminated	`NCT03204695` - WAVECREST Post Market Clinical Follow-Up (PMCF) Study	N/A
Completed	`NCT04722679` - A Study to Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.
Completed	`NCT04297072` - Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists
Recruiting	`NCT05320627` - Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation	Phase 4
Recruiting	`NCT03088072` - A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure	Phase 4
Completed	`NCT04519944` - Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

NCT number	NCT03917563
Study type	Interventional
Source	Xijing Hospital
Contact	Ling Tao, Ph.D.,M.D.
Phone	86-29-84775183
Email	lingtao@fmmu.edu.cn
Status	Not yet recruiting
Phase	N/A
Start date	April 20, 2019
Completion date	April 20, 2024

Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology — RECORD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms